Position in IMVT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,853,000
+$1,369,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#64
of 226 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Sep 30, 2024CallValue
$2,223,780
CallShares
78,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. IMVT ranks #67 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in IMVT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,853,000 | 100,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,484,000 | 100,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,084,000 | 200,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,836,000 | 300,000 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $7,348,700 | 430,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,477,000 | 100,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,223,780 | 78,000 | Call | Sole | 2024-11-13 | |
| 2024-09-30 | $6,414,750 | 225,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,136,723 | 346,088 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,433,520 | 54,300 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $4,665,564 | 144,400 | Call | Sole | 2024-05-14 | |
| 2024-03-31 | $9,208,350 | 285,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,534,850 | 345,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,917,759 | 128,100 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $11,517,000 | 300,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,932,200 | 260,000 | Shares | Sole | 2023-08-21 | |
| 2021-09-30 | $260,700 | 30,000 | Call | Sole | 2021-11-12 | |
| 2021-06-30 | $317,100 | 30,000 | Call | Sole | 2021-08-13 | |
| 2021-03-31 | $1,122,800 | 70,000 | Call | Sole | 2021-05-14 | |
| 2020-12-31 | $3,464,250 | 75,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||